Maresyl

Xylometazoline Hydrochloride, the active ingredient in Maresyl, is an imidazoline nasal decongestant presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Maresyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maresyl, an imidazoline nasal decongestant, is used to alleviate congestion in the upper respiratory tract.

- Common cold: reduces nasal blockage and improves airflow. - Sinusitis: eases sinus‑related congestion and pressure. - Allergic rhinitis: diminishes swelling of nasal mucosa caused by allergens.

Maresyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing shortly after application. - Headache. - Altered taste or bitter taste. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) with prolonged use. - Severe hypertension or hypertensive crisis. - Allergic reaction such as rash, itching, or swelling. - Nasal ulceration or perforation. - Cardiac arrhythmias. - Acute ocular pressure increase in susceptible individuals.

Before using Maresyl, consider the following safety measures.

- Do not exceed recommended duration: limit use to 3‑5 days to avoid rebound congestion. - Avoid use in patients with severe hypertension: monitor blood pressure if underlying condition exists. - Caution in children under 2 years: consult a healthcare professional before use. - Do not combine with other nasal decongestants: risk of additive systemic effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Maresyl can interact with other medications that affect vascular tone or adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may precipitate hypertensive crisis. - Other topical nasal decongestants: combined use increases risk of systemic vasoconstriction.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (e.g., beta‑blockers, ACE inhibitors): may reduce their efficacy. - Sympathomimetic drugs (e.g., pseudoephedrine): monitor for excessive cardiovascular stimulation. - Certain antidepressants (e.g., tricyclics): may enhance adrenergic effects.